|
Marché Fermé -
NYSE
22:00:02 12/11/2026
|
Pré-ouverture 13:06:36 | |||
| 40,65 USD | -1,07% |
|
40,60 | -0,12% |
| 12:57 | Novo Nordisk sollicite l'approbation de l'etavopivat aux USA et en UE |  |
| 12:42 | Novo Nordisk demande l’autorisation de son médicament contre la drépanocytose | MT |
Principaux concurrents
Ajouter à une liste 0 sélectionné | Varia. | Varia. 5j. | Variation 1 mois | Variation 3 mois | Varia. 1 janv. | Varia. 1an | Varia. 3ans | Varia. 5ans | Varia. 10ans | Capi.($) | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0,70% | +4,58% | +20,69% | +16,96% | +32,81% | +40,23% | +138,79% | +449,69% | +1 737,62% | 1 271 Md | |
| +1,11% | +4,11% | +7,50% | +8,69% | +37,00% | +45,85% | +92,54% | +71,82% | +139,32% | 683 Md | |
| -0,18% | +2,15% | +4,74% | +18,37% | +28,87% | +26,25% | +112,46% | +151,73% | +366,64% | 520 Md | |
| -0,81% | +3,48% | +12,26% | +11,48% | +23,07% | +39,32% | +69,17% | +9,46% | +72,98% | 389 Md | |
| -0,16% | +0,01% | +1,03% | +10,56% | +39,61% | +60,69% | +44,94% | +74,94% | +129,79% | 362 Md | |
| -0,10% | +0,83% | +12,47% | +8,44% | +22,43% | +26,90% | +58,57% | +76,09% | +85,97% | 304 Md | |
| +0,04% | +0,29% | +17,43% | +19,32% | +1,31% | +3,53% | +36,32% | +55,78% | +220,01% | 286 Md | |
| -0,22% | +1,47% | +11,85% | +12,23% | +42,70% | +38,89% | +74,73% | +120,95% | +213,38% | 253 Md | |
| -1,05% | +0,23% | +11,65% | +23,61% | +36,83% | +36,10% | +121,22% | +148,89% | +119,77% | 208 Md | |
| -0,39% | +2,25% | +7,34% | -7,63% | -15,30% | -13,54% | -60,27% | -25,75% | +140,93% | 180 Md | |
| -2,11% | -3,51% | +1,51% | +9,58% | +15,78% | +11,44% | -2,20% | -42,03% | -11,54% | 164 Md | |
| -0,81% | +0,02% | +7,03% | +3,21% | +19,69% | +24,97% | +45,22% | +189,72% | +489,80% | 138 Md | |
| -0,94% | -1,28% | +8,23% | -2,17% | +15,54% | +26,98% | +23,14% | +4,86% | +10,56% | 127 Md | |
| -0,25% | +0,47% | +12,69% | +22,57% | +31,30% | +28,11% | +129,51% | +379,05% | +653,02% | 124 Md | |
| -0,11% | +4,96% | +24,24% | +14,99% | +6,25% | -2,82% | +3,05% | -2,42% | +13,88% | 117 Md | |
| -6,97% | -4,19% | +8,24% | +263,36% | +684,50% | +766,15% | +230,26% | +0,07% | - | 93,61 Md | |
| +0,28% | +1,08% | +8,98% | +2,91% | +4,71% | +5,52% | +35,77% | -3,72% | -0,59% | 101 Md | |
| -0,86% | +5,35% | +24,70% | +19,20% | +23,23% | +39,53% | +19,06% | +50,70% | +126,59% | 95,45 Md | |
| +0,46% | +5,51% | +16,39% | +0,08% | -12,88% | -11,27% | +52,14% | +70,81% | +553,81% | 73,52 Md | |
| Moyenne | -0,03% | +0,91% | +11,53% | +23,99% | +54,60% | +62,78% | +64,44% | +93,72% | +281,22% | 289 Md | |
| Moyenne pondérée par Capi. | -0,13% | +2,10% | +12,11% | +16,97% | +37,51% | +44,56% | +83,59% | +164,46% | +549,65% |
- Bourse
- Actions
- Action NOVO B
- Action NVO
- Secteur Novo Nordisk A/S
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
